Haishan Luo

Title: Haishan Luo: Innovator in Antibody Development

Introduction

Haishan Luo is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a focus on treating diseases such as cancer and autoimmune disorders, his work has garnered attention in the scientific community.

Latest Patents

Haishan Luo holds 2 patents that showcase his innovative approach to antibody development. His latest patents include "Anti-PD-1 antibodies and uses thereof," which describes anti-PD-1 antibodies and antigen-binding fragments. This patent also details nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods for producing and using these antibodies to treat or prevent diseases like cancers and autoimmune diseases. Another significant patent is "Anti-PD-L1 antibodies and uses thereof," which provides anti-PD-L1 antibodies and antigen-binding fragments, along with nucleic acids encoding these antibodies, compositions containing them, and methods for their production and use in treating cancer, infectious diseases, and autoimmune diseases.

Career Highlights

Throughout his career, Haishan Luo has worked with notable companies in the healthcare sector. He has been associated with Shanghai Yunyi Healthcare and Technology Co., Ltd. and Jiangsu Hyamab Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in antibody therapies.

Collaborations

Haishan Luo has collaborated with several professionals in his field, including Lile Liu and Xinxiu Yang. These collaborations have further enhanced his research and development efforts in antibody technology.

Conclusion

Haishan Luo's contributions to the field of antibody development are noteworthy, particularly in the context of treating serious diseases. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.